Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Evidence for in vivo transport of bioactive nitric oxide in human plasma.

Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiss C, Strauer BE, Feelisch M, Kelm M.

J Clin Invest. 2002 May;109(9):1241-8.

2.

Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature.

Lauer T, Kleinbongard P, Preik M, Rauch BH, Deussen A, Feelisch M, Strauer BE, Kelm M.

Basic Res Cardiol. 2003 Mar;98(2):84-9.

PMID:
12607129
3.

Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical Study on the fate of NO in human blood.

Rassaf T, Kleinbongard P, Preik M, Dejam A, Gharini P, Lauer T, Erckenbrecht J, Duschin A, Schulz R, Heusch G, Feelisch M, Kelm M.

Circ Res. 2002 Sep 20;91(6):470-7.

4.
6.
8.

Role of nitric oxide towards vasodilator effects of substance P and ATP in human forearm vessels.

Shiramoto M, Imaizumi T, Hirooka Y, Endo T, Namba T, Oyama J, Hironaga K, Takeshita A.

Clin Sci (Lond). 1997 Feb;92(2):123-31.

PMID:
9059312
9.

Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.

Lauer T, Preik M, Rassaf T, Strauer BE, Deussen A, Feelisch M, Kelm M.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12814-9. Epub 2001 Oct 16.

10.

Does lipoprotein(a) impair endothelial function?

Schlaich MP, John S, Langenfeld MR, Lackner KJ, Schmitz G, Schmieder RE.

J Am Coll Cardiol. 1998 Feb;31(2):359-65.

11.

Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.

Passauer J, Büssemaker E, Lässig G, Pistrosch F, Fauler J, Gross P, Fleming I.

Clin Sci (Lond). 2003 Oct;105(4):513-8.

PMID:
12826020
12.

Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men.

Nietlispach F, Julius B, Schindler R, Bernheim A, Binkert C, Kiowski W, Brunner-La Rocca HP.

Hypertension. 2007 Jul;50(1):82-8. Epub 2007 May 14.

14.

Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels.

Fok H, Jiang B, Clapp B, Chowienczyk P.

Hypertension. 2012 Nov;60(5):1220-5. doi: 10.1161/HYPERTENSIONAHA.112.198788. Epub 2012 Oct 8.

15.

Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery.

Cannon RO 3rd, Schechter AN, Panza JA, Ognibene FP, Pease-Fye ME, Waclawiw MA, Shelhamer JH, Gladwin MT.

J Clin Invest. 2001 Jul;108(2):279-87.

16.
17.

Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.

Haefeli WE, Linder L, Lüscher TF.

Hypertension. 1997 Oct;30(4):912-7.

18.

Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients.

Lewis TV, Dart AM, Chin-Dusting JP, Kingwell BA.

Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2782-7.

19.

[Role of endothelium-derived nitric oxide in sustained flow-dependent dilatation of human peripheral conduit arteries].

Bellien J, Joannidès R, Iacob M, Eltchaninoff H, Thuillez Ch.

Arch Mal Coeur Vaiss. 2003 Jul-Aug;96(7-8):738-41. French.

PMID:
12945214
20.

Smooth muscle-derived nitric oxide is elevated in isolated forearm veins in human alcoholic cirrhosis.

Ryan J, Jennings G, Dudley F, Chin-Dusting J.

Clin Sci (Lond). 1996 Jul;91(1):23-8.

PMID:
8774256

Supplemental Content

Support Center